Applying CRISPR-Cas9 technology, we generated a human t(3;8) cell line model with an eGFP reporter cloned 3’ of EVI1. This unique model was used to investigate how enhancer-promoter interactions drive oncogenic EVI1 expression in leukemia. Here, RUNX1 is linked to leukemia.